The Lancet China Covid 19 Vaccine - Covid-19 Realtime Info
The lancet published the phase 1 trial results of a possible covid 19 vaccine from china.
The lancet china covid 19 vaccine. But it has to go through more trials before being put on the market. It seems to be safe and effective. From china and the united kingdom respectively the two stars on the track of adenovirus vector vaccine display a one on one competition. Such research was done incredibly fast and rigorously through close cooperation within china at a time of national emergency.
China has also been at the forefront of vaccine research with promising results of early trials of a recombinant adenovirus type 5 vectored covid 19 vaccine developed in china published in the lancet in may and july. Feng cai zhu and colleagues completed a single centre phase 2 randomised trial in wuhan china using a recombinant adenovirus type 5 vectored covid 19 vaccine. This candidate vaccine is now undergoing phase 3 trials in brazil south africa and the uk. We did a dose escalation single centre open label non randomised phase 1 trial of an ad5 vectored covid 19 vaccine in wuhan china.
On july 20 th the lancet published two papers online at the same time revealing the results of clinical trials for two covid 19 vaccines.